Core Viewpoint - BrainCo, a leading company in the brain-computer interface (BCI) sector, has successfully completed a financing round of approximately 2 billion RMB, marking it as the second-largest financing in the global BCI market, following Neuralink [2] Financing and Investment - The recent financing attracted a prestigious lineup of investors, including IDG, Huaden International, and major industry players like Lens Technology and Lingyi iTech [2] - BrainCo's financing history shows a consistent increase in capital recognition, with significant rounds including 400 million USD in Series A in 2019 and 30 million USD in Pre-B and 20 million USD in Series B in 2025 [3] - The company is preparing for an IPO, potentially in Hong Kong or mainland China, with a valuation exceeding 1.3 billion USD anticipated for the upcoming round [3] Company Background and Product Development - Founded in February 2015 by Han Bicheng, BrainCo focuses on non-invasive BCI technology, having developed products like smart prosthetics and sleep improvement devices [3][4] - The company has received FDA and CE certifications, making it one of the few globally to achieve large-scale production of BCI products [4] Future Plans and Market Potential - BrainCo aims to assist 1 million individuals with physical disabilities and 10 million patients suffering from Alzheimer's, autism, and insomnia over the next 5 to 10 years [5] - The company is committed to advancing non-invasive BCI solutions for mental health issues like depression and Alzheimer's, aligning with China's increased investment in brain science [5] Industry Landscape - Neuralink remains the highest-valued BCI company globally, with a valuation of 9 billion USD post-E round financing in 2025 [5] - The BCI sector is gaining traction in the capital market, with several A-share companies experiencing significant stock performance related to BCI concepts [6] - Companies like Aihuilong and Kefu Medical are entering the BCI space, indicating a growing interest and investment in this emerging field [6] Investment Opportunities - The BCI industry is in its early commercialization phase, with a focus on thematic investment strategies [6] - There is potential for significant revenue generation in non-invasive BCI products, as well as opportunities in software, hardware, and experimental materials related to BCI [6]

Core Viewpoint - The article discusses the integration of 82 medical service pricing items related to the nervous system by the Sichuan Provincial Medical Insurance Bureau, including the pricing for brain-machine interface medical services, which will take effect on April 30 this year, with the highest implantation fee set at 6,583 yuan per instance [3][4]. Group 1 - The Sichuan Provincial Medical Insurance Bureau has issued a notification to consolidate 82 pricing items for nervous system medical services [3][4]. - The government-guided price for brain-machine interface services includes a maximum implantation fee of 6,583 yuan per instance [3][4]. - The pricing integration aims to clarify the medical insurance payment categories for these services [3][4]. Group 2 - The article lists various companies involved in the brain-machine interface and related technologies, including innovative medical firms such as Xinhua Medical, Yanjian Technology, and others [4]. - The integration of pricing is expected to impact companies engaged in brain signal acquisition and neuro-rehabilitation technologies [4].

Core Viewpoint - The performance of Daoshi Technology is significantly influenced by cyclical factors, particularly in the copper and cobalt sectors, which have shown recovery since 2024, similar to the lithium battery materials cycle in 2021 [1][20]. Financial Performance - As of January 5, 2026, Daoshi Technology reported a revenue of 6.00 billion yuan for the first three quarters of 2025, a slight decline of 1.79% year-on-year, while net profit attributable to shareholders surged by 182.45% to 415.45 million yuan [7][8]. - The company’s net profit has shown volatility over the years, with a peak of 562 million yuan in 2021, a drop to 86 million yuan in 2022, and a loss of 28 million yuan in 2023, before recovering to 157 million yuan in 2024 and 415 million yuan in 2025 [9][11]. Business Structure and Strategy - Daoshi Technology has diversified its business from traditional ceramic materials to include carbon materials, lithium battery materials, and strategic resources like copper and cobalt, which have become significant revenue contributors [12][16]. - The company has shifted its focus towards upstream resources, particularly in the Democratic Republic of Congo, where it plans to produce 30,000 tons of cathode copper and 2,710 tons of cobalt by mid-2027 [19][16]. Market Trends and Future Outlook - The recent surge in stock price is attributed to the excitement around brain-computer interface technologies, particularly following announcements from industry leaders like Elon Musk [4][31]. - Daoshi Technology is actively developing solid-state battery materials, which are expected to be crucial for future growth, including single-walled carbon nanotubes and high-nickel precursors [21][29]. - The company is positioned to benefit from the increasing demand for solid-state battery materials, although current financial contributions from this segment are not yet realized [31][29].

每经AI快讯，有投资者在投资者互动平台提问：请问公司关联的微灵医疗与脑虎科技是否涉及脑机接 口相关技术？ 力合科创（002243.SZ）1月8日在投资者互动平台表示，微灵医疗是公司的参股企业，主要从事医疗级 全植入式无线脑机接口系统研发；公司未投资脑虎科技，敬请您注意投资风险。 （记者 张海妮） ...

每经AI快讯，有投资者在投资者互动平台提问：据了解，公司持有脑机接口公司微灵医疗万分之零点 二四的股权，是否属实？ 力合科创（002243.SZ）1月8日在投资者互动平台表示，公司通过在管基金深圳南山西丽科教城验证一 期私募股权投资基金合伙企业（有限合伙）持有微灵医疗的股权，具体持股情况以工商登记信息为准。 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前核实。据此操作，风险自担。 每日经济新闻 （记者 张海妮） ...

智通财经APP讯，南京熊猫(600775.SH)发布风险提示公告称，公司关注到近期脑机接口概念引发市场 广泛关注，现作如下说明：公司参与了"面向智能显示的高速率脑机交互技术研发"项目(简称"该项目") 的子课题"基于脑机接口技术的多模态人机交互系统集成关键技术研发"。公司参与的子课题属于非核心 技术部分。截至目前，公司向该项目牵头单位及其主管部门提交了一套面向智能显示的脑机交互系统终 端。该项目后续的相关工作由项目牵头单位及其主管部门组织实施。该项目及公司参与的子课题，不会 对公司生产经营产生影响，公司目前没有与该项目相关的成熟产品，亦未形成销售收入。 ...

Group 1: Commercial Aerospace - Arrow Technology has begun construction on China's first offshore reusable rocket production base in Zhejiang Qiantang, marking a significant milestone in domestic aerospace capabilities [4] - Starlink has connected over 9 million active users across seven continents, indicating a growing scale in satellite direct-to-mobile services, with related companies like Xinwei Communication and Aerospace HuanYu seeing stock increases of 13.71% and 7.95% respectively [5] - Shunhao Co., which holds shares in Beijing Trajectory Technology and its parent company, is leading the construction of Beijing's Space Data Center, resulting in a stock price surge [7] - The commercial aerospace sector is entering a high-speed development phase driven by capital, technology, and market dynamics, with companies like Srey New Materials and Shangda Co. experiencing stock increases of 14.52% and 7.55% respectively [10] - The commercial aerospace market in China is projected to reach 7.8 trillion yuan by 2030, with companies like Tongyu Communication and Mengsheng Electronics seeing stock increases of 20.91% and 14.98% respectively [12] Group 2: Space Technology and Reusability - The domestic reusable rocket verification phase is underway, with institutions optimistic about the long-term investment logic of reusable rockets [16] - Hailanxin, which previously won a bid for a project related to a recovery ship for rockets, saw its stock rise by 20% following the news of the construction of the reusable rocket base [17] Group 3: Network Security - Shengbang Security is a leading player in the network security sector, focusing on vulnerability detection and application defense, with a recent stock increase of 9.73% after announcing a new high-performance encryption gateway for satellite communication [19] Group 4: Brain-Computer Interface - The brain-computer interface sector is experiencing significant growth, with companies like Aipeng Medical seeing a stock increase of 20% following market excitement around Elon Musk's production announcements [23] - Yanshan Technology has developed a brainwave model capable of precise Chinese language recognition, leading to a stock increase after announcing its advancements in practical brain-computer interfaces [25] Group 5: Semiconductor Industry - The Ministry of Commerce has initiated an anti-dumping investigation into imported dichlorodihydrosilane from Japan, which may impact the semiconductor materials market [27] - The domestic semiconductor materials market is expected to benefit from accelerated localization efforts, with companies like Tongcheng New Materials and Jinhong Gas seeing stock increases of 11.11% [27]

Market Overview - The Asia-Pacific markets mostly retreated on January 8, with the Nikkei 225 index down by 1.63%, and both A-shares and Hong Kong stocks experiencing corrections [1] - U.S. stock index futures also declined, while precious metals saw a significant drop, and most domestic commodity futures closed lower [1] A-Share Market Performance - The Shanghai Composite Index closed down by 0.07%, the Shenzhen Component Index fell by 0.51%, and the ChiNext Index decreased by 0.82% [2] - The total trading volume in the Shanghai and Shenzhen markets was 2.8 trillion yuan, a decrease of 53.8 billion yuan from the previous trading day, marking the fourth consecutive day with a trading volume exceeding 2.5 trillion yuan [1][2] Sector Performance - The commercial aerospace sector saw a collective surge, with over twenty constituent stocks hitting the daily limit, including Lushin Investment which achieved eight consecutive gains [2] - The brain-computer interface concept continued its strong performance, with stocks like Innovation Medical and Nanjing Panda achieving four consecutive gains [2] - The controlled nuclear fusion concept was active, with companies like China First Heavy Industries and China National Machinery Industry Corporation achieving two consecutive gains [2] - In contrast, sectors such as large finance, rare earth magnets, and non-ferrous metals experienced significant declines, particularly in the securities sector where Huayin Securities hit the daily limit down [2] Commodity Futures - Most domestic commodity futures closed lower, with the shipping index dropping over 8%, platinum and nickel down over 6%, and industrial silicon down over 4% [4] - Notably, the multi-crystalline silicon futures contract hit the limit down, following a meeting with the market regulator regarding monopoly risks and compliance requirements for major solar companies [4] Precious Metals - Precious metals prices saw a decline, with gold prices falling below $4,450 per ounce and silver prices dropping to around $75.87 per ounce [4] Cryptocurrency Market - The cryptocurrency market experienced a collective downturn, with Bitcoin falling below $90,000, down nearly 3%, and Ethereum dropping over 4% to below $3,100 [6][7]

| | 沪股通 ( | 1月8日 | ) | | --- | --- | --- | --- | | 排名 | 股票代码 | 股票名称 | 成交金额(亿元) | | 1 | 688256 | 惠武纪 | 34.09 | | 2 | 668109 | 紫等时,不 | 25.08 | | 3 | 688041 | 海米信息 | 24.43 | | 4 | 601138 | 工业富联 | 18.19 | | 5 | 601318 | 中国平安 | 17.48 | | 6 | 603986 | 兆易创新 | 15.34 | | 7 | 615009 | 贵州茅台 | 12.32 | | 8 | 600030 | 中信证券 | 11.55 | | 9 | 688012 | 中微公司 | 11.39 | | 10 | 601600 | 中国铝业 | 10.59 | | | 深胺通( | 1月8日 | ) | | 排名 | 股票代码 | 股票名称 | 成交金额(亿元) | | 1 | 300750 | 宁德时代 | 42.31 | | 2 | 002475 | 立讯精密 | 32.36 | | 3 | 300308 | 中 ...

龙虎榜方面，商业航天概念今日集体爆发，人气股金风科技尾盘涨停晋级3连板，获一家实力游资（中国银河证券大连黄河路）大幅净买入3.79亿。航天电 器获多路资金青睐，获深股通买入0.95亿，两家机构买入3.58亿，两家一线游资（华鑫证券上海宛平南路、中泰证券湖北分公司）分别买入2.59亿、0.73亿。 一、沪深股通前十大成交 今日沪股通总成交金额为1484.13亿，深股通总成交金额为1763.44亿。 | | 沪股通 ( | 1月8日 ) | | | --- | --- | --- | --- | | 排名 | 股票代码 | 股票名称 | 成交金额(亿元) | | 1 | 688256 | 寒武纪 | 34.09 | | 2 | 668109 | 三十四年薪 | 25.08 | | 3 | 688041 | 海光信息 | 24.43 | | 4 | 601138 | 工业富联 | 18.19 | | 5 | 601318 | 中国部安 | 17.48 | | 6 | 603986 | 兆易创新 | 15.34 | | 7 | 615009 | 贵州茅台 | 12.32 | | 8 | 600030 | 中信证券 | ...